WESPAC Advisors SoCal’s OncoSec Medical Incorporated ONCS Stock Holding History

WESPAC Advisors SoCal’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1	Closed	–	–	351
2019 Q1	$0	Hold	1	–	–	﹤0.01%	374
2018 Q4	$0	Hold	1	–	–	﹤0.01%	378
2018 Q3	$0	Buy	+1	New	+$307	﹤0.01%	324
2018 Q2	–	Sell	-1	Closed	–	–	283
2018 Q1	$0	Hold	1	–	–	﹤0.01%	307
2017 Q4	$0	Hold	1	–	–	﹤0.01%	295
2017 Q3	$0	Hold	1	–	–	﹤0.01%	280
2017 Q2	$0	Hold	1	–	–	﹤0.01%	260
2017 Q1	$256	Hold	1	–	–	﹤0.01%	248
2016 Q4	$246	Hold	1	–	–	﹤0.01%	255
2016 Q3	$342	Hold	1	–	–	﹤0.01%	279
2016 Q2	$328	Hold	1	–	–	﹤0.01%	277
2016 Q1	$510	Hold	1	–	–	﹤0.01%	279
2015 Q4	$0	Buy	+1	New	+$752	﹤0.01%	270

Other funds holding ONCS

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WESPAC Advisors SoCal's ONCS Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of OncoSec Medical Incorporated (ONCS) in Q2 2019, closing a stake of 1 share.

WESPAC Advisors SoCal first reported a position in ONCS in Q4 2015 and held it in 13 quarters. The position peaked at $510 in Q1 2016. 20 funds tracked by Wall St. Rank hold ONCS as of Q2 2019.

WESPAC Advisors SoCal reported no remaining OncoSec Medical Incorporated position as of Q2 2019 after selling out during the quarter.
WESPAC Advisors SoCal sold 1 OncoSec Medical Incorporated share in Q2 2019.
WESPAC Advisors SoCal first reported a position in OncoSec Medical Incorporated in Q4 2015 and held it in 13 quarters.
WESPAC Advisors SoCal's OncoSec Medical Incorporated position peaked at $510 in Q1 2016.
20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.